40 分钟on MSN
MindRank in phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based ...
The Brighterside of News on MSN
New study provides a key breakthrough in cancer therapy and synthetic biology
Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics. Even cells with the same DNA can act differently because their molecules ...
Researchers at the Francis Crick Institute, a biomedical research centre based in London, and AlveoliX, a leading Swiss ...
New math model controls biological noise at single-cell level, offering a path to tackle cancer relapse and drug resistance.
RICHMOND - Governor Glenn Youngkin recently announced $6.2 million in Growth and Opportunity for Virginia (GO Virginia) grants for 10 projects that advance Virginia’s economic competitiveness through ...
Brenna Henn had a long-term grant to study the genetic diversity of Africans and people of African descent. Then her N.I.H.
Illinois’ hidden budgeting process let lawmakers hand out 2,815 grants, including $7 million to move the University of ...
Two University of Arizona researchers have been working on a wearable healthcare device using artificial intelligence to ...
Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...
Learning redesign in a suburban district makes career readiness central to everyone’s academic and personal growth in high ...
Researchers at the Francis Crick Institute and AlveoliX have developed the first human ‘lung-on-chip’ model using stem cells taken from only one person.
MDR, MDSAP, and FDA audits demand rigorous preparation, lifecycle traceability, and risk-based compliance for global market ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈